Clearday (CLRD) Stock Price, News & Analysis
Company Description
Clearday (OTC Link: CLRD) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $65.4K.
CLRD has gained 1150.0% over the past year. Shares last traded at $0.0025.
This page collects what Stock Titan holds for CLRD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clearday (CLRD) stock last closed at $0.0025. Over the past 12 months, the stock has gained 1150.0%. At a market capitalization of $65.4K, CLRD is classified as a micro-cap stock with approximately 27.1M shares outstanding.
Latest News
Clearday has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 3 with negative movement. Key topics include management, conferences. View all CLRD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Clearday (CLRD) currently stands at 65 shares, representing 0.0% of the float. Since August 2025, short interest has increased by 1525.0%. This relatively low short interest suggests limited bearish sentiment. The 7.2 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Clearday (CLRD) currently stands at 7.2 days, up 622% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 622% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.2 days.
CLRD Company Profile & Sector Positioning
Clearday (CLRD) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CLRD often look at related companies in the same sector, including Novo Integrated Sciences Inc (NVOS), Genesis Heal (GENN), Assure Hldgs (IONM), Jack Nathan Med (JNHMF), and Imac Hldgs Inc (BACK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLRD's relative position within its industry.